drugset / Trial / NCT03993106
A Study of sEphB4-HSA in Kaposi Sarcoma
NaSingle-groupOpen-labelTreatment
Summary
sEphB-HSA may prevent tumor cells from multiplying and blocks several compounds that promote the growth of blood vessels that bring nutrients to the tumor. The purpose of this study is to learn if sEphB4-HSA will decrease the number or size of Kaposi sarcoma lesions in people.
Timeline
- Start
- 2020-09-17
- Primary completion
- 2024-12
- Completion
- 2025-06
Drugs
| Evaluation | Drug | Modality | Dose | Route |
|---|---|---|---|---|
| Subject | sEphB4-HSA | Protein / enzyme biologic | — | Intravenous |